Hematologic Malignancies Guidelines

Hematologic Malignancies Chairs & Task Force Members

Cancer Immunotherapy Guidelines-HEME Lymphoma Chair

Michael R. Bishop, MD - University of Chicago

Task Force

• Stephen M. Ansell, MD, PhD - Mayo Clinic
• Koen Van Besien, MD - Weill Cornell Medical College
• Joshua Brody, MD - Icahn School of Medicine at Mount Sinai
• Mitchell Cairo, MD - New York Medical College at Maria Fareri Children's Hospital
• Jonathan W. Friedberg, MD, MMSc - University of Rochester Medical Center School of Medicine and Dentistry
• Brad S. Kahl, MD - Washington University School of Medicine
• Justin Kline MD - The University of Chicago
• James N. Kochenderfer, MD - National Cancer Institute, National Institutes of Health
• Larry W. Kwak, MD, PhD - City of Hope National Medical Center
• Ronald Levy, MD - Stanford University School of Medicine
• David L. Porter, MD - University of Pennsylvania
• Karl Schwartz - Patients Against Lymphoma
• Margaret A. Shipp, MD - Dana-Farber Cancer Institute
• John M. Timmerman, MD - University of California, Los Angeles
• Michael Werner- Globe Union Group, Inc.

Cancer Immunotherapy Guidelines-HEME Acute Leukemia Chair

Michael Boyiadzis, MD, MHSc - University of Pittsburgh School of Medicine, Cancer Institute, and Medical Center

Task Force

• Austin John Barrett, MD - National Cancer Institute, National Institutes of Health
• Jill Brufsky, Pharm D - University of Pittsburgh Cancer Institute
• Jorge Cortes, MD - The University of Texas MD Anderson Cancer Center
• Stephen J. Forman, MD - City of Hope National Medical Center
• Ephraim J. Fuchs, MD - Johns Hopkins University School of Medicine
• Steven D. Gore MD - Yale Cancer Center
• Marcos de Lima, MD - Case Western Reserve University
• Mark R. Litzow, MD - Mayo Clinic
• Jeffrey Miller, MD - University of Minnesota
• John M. M. Pagel, MD, PhD - Swedish Cancer Institute
• Richard M. Stone, MD - Dana-Farber Cancer Institute
• Martin S. Tallman, MD - Memorial Sloan Kettering Cancer Center
• Edmund K. Waller, MD, PhD, FACP - Winship Cancer Institute, Emory University
• Ann Welsh, RN, OCN - University of Pittsburgh Medical Center

Cancer Immunotherapy Guidelines-HEME Multiple Myeloma Chair

Madhav V. Dhodapkar, MD - Yale University

Task Force

• Rafat Abonour, MD - Indiana University School of Medicine
• Kenneth C. Anderson, MD - Dana-Farber Cancer Institute
• David Avigan, MD - Beth Israel Deaconess Medical Center
• Lisa Barbarotta, APRN - Smilow Cancer Hospital at Yale New Haven
• P. Leif Bergsagel, MD - Mayo Clinic
• Ivan Borrello, MD - Johns Hopkins School of Medicine
• Ajai Chari, MD - Icahn School of Medicine at Mount Sinai
• Adam Cohen, MD - Abramson Cancer Center at the University of Pennsylvania
• Sundar Jagannath, MD - Icahn School of Medicine at Mount Sinai
• Anuj Mahindra, MD - Helen Diller Family Comprehensive Cancer at University of California, San Francisco
• Nikhil C. Munshi, MD - Dana-Farber Cancer Institute
• Robert Z. Orlowski, MD, PhD - The University of Texas MD Anderson Cancer Center
• Frits Van Rhee, MD, PhD - University of Arkansas for Medical Sciences
• Stephen J. Russell, MD, PhD - Mayo Clinic
• David Siegel, MD, PhD - Hackensack University Medical Center